GlassScriptPhysician profile
Erin K Pardee
NPI 1275919722
$2,787.23
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $54.14 · 2022: $1,096 · 2023: $1,602 · 2024: $34.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,637.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,637.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $753.54 | 2022-2023 | |
| Impulse Dynamics (USA) INC. | $712.21 | 2022-2024 | Optimizer, Optimizer |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $348.97 | 2022-2023 | Lifevest |
| Janssen Pharmaceuticals, INC | $219.17 | 2022-2023 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $208.70 | 2022-2023 | Jardiance |
| Amgen INC. | $137.08 | 2023 | Repatha |
| Esperion Therapeutics, INC. | $88.38 | 2023 | Nexletol |
| Boston Scientific Corporation | $87.79 | 2023 | Bodyguardian, Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Abbott Laboratories | $74.90 | 2023 | Aveir, Gallant, Jot Dx |
| E.R. Squibb & Sons, L.L.C. | $38.20 | 2022-2023 | Eliquis |
| Pfizer INC. | $36.14 | 2021 | |
| Sanofi-Aventis U.S. LLC | $35.85 | 2023 | |
| Baxter Healthcare | $28.30 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Medtronic, INC. | $18.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Pardee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.